BackRegeneron Pharmaceuticals Overview

Regeneron Pharmaceuticals Current Assets

Regeneron Pharmaceuticals's current assets is $21B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$20.80B
↑ 15.65% YoYΔ $2.81B vs prior year quarter

Peer trimmed avg / median

Loading

Regeneron Pharmaceuticals Current Assets History

Loading

Regeneron Pharmaceuticals vs. peers: Current Assets Comparison

Loading

Regeneron Pharmaceuticals Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Regeneron Pharmaceuticals (0R2M.L) FAQ

As of the most recent data (September 2026), 0R2M.L shows a current assets of $21B. That compares with $18B in the prior-year period — up 15.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 0R2M.L's current assets is now $21B (was $18B) — a 15.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Regeneron Pharmaceuticals is outperforming or lagging.

Tracking 0R2M.L's current assets over time shows whether Regeneron Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $21B That compares with $18B in the prior-year period — up 15.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Regeneron Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $21B) with ownership activity and broader fundamentals.

Regeneron Pharmaceuticals's current assets is $21B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.

Questions & Answers